Back to search

University of Minnesota

Personalizing Colorectal Cancer Care: Opportunities for Pharmacogenomics

Abstract

dc:description.abstract

A diagnosis of metastatic colorectal cancer impacts nearly 30,000 Americans a year, and while treatments are available, they come with the risk of morbidity and mortality. Personalized medicine, the use of an individual’s genetic information to tailor their treatment, is used in oncology to determine somatic, druggable targets to select therapy. It also provides an opportunity to understand the likelihood that an individual would develop toxicities during treatment or fail to respond to treatment. This approach has not been integrated into clinical practice at the same level as the targeted approach. This dissertation explores the opportunities for germline pharmacogenetic testing to inform chemotherapy and non-chemotherapy medication selection in a historical cohort of Americans with metastatic colorectal cancer and models the theoretical cost-effectiveness of implementing this approach.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Rivers, Zachary

Subjects

dc:subject × 4

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Citation
Rivers, Zachary. (2021). Personalizing Colorectal Cancer Care: Opportunities for Pharmacogenomics. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/250032.

Chain of custody

source
Harvested from
University of Minnesota
Base URL
conservancy.umn.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Rivers, Zachary. Personalizing Colorectal Cancer Care: Opportunities for Pharmacogenomics. 2021. https://hdl.handle.net/11299/250032